Aeolus Pharmaceuticals, Inc.
AOLS
$0.0001
$0.000.00%
| 06/30/2017 | 03/31/2017 | 12/31/2016 | 09/30/2016 | 06/30/2016 | |
|---|---|---|---|---|---|
| Revenue | 13.00K | 129.00K | 83.00K | 546.00K | 660.00K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 13.00K | 129.00K | 83.00K | 546.00K | 660.00K |
| Cost of Revenue | 425.00K | 594.00K | 489.00K | 984.00K | 904.00K |
| Gross Profit | -412.00K | -465.00K | -406.00K | -438.00K | -244.00K |
| SG&A Expenses | 537.00K | 570.00K | 681.00K | 585.00K | 628.00K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 962.00K | 1.16M | 1.17M | 1.57M | 1.53M |
| Operating Income | -949.00K | -1.04M | -1.09M | -1.02M | -872.00K |
| Income Before Tax | -949.00K | -1.04M | -1.09M | -1.02M | -872.00K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -949.00K | -1.04M | -1.09M | -1.02M | -872.00K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -949.00K | -1.04M | -1.09M | -1.02M | -872.00K |
| EBIT | -949.00K | -1.04M | -1.09M | -1.02M | -872.00K |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 152.09M | 152.09M | 152.09M | 152.11M | 151.65M |
| Average Diluted Shares Outstanding | 152.09M | 152.09M | 152.09M | 152.11M | 151.65M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
